Tessa Therapeutics Announces U.S. FDA Regenerative Medicine Ad...
SINGAPORE, Feb. 27, 2020 /PRNewswire-AsiaNet/ -- RMAT designation follows positive proof-of-concept data from two independent Phase I/II clinical studies conducted by Baylor College of Medicine and University of North Carolina Lineberger Comprehensive Cancer Center for the autologous T cell ther...
Authors: LATEST ASIANET NEWS RELEASES